Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Maffezzini

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Surgical Oncology|April 4, 2009
The magnitude of the problem and the burden of physicians and patient decisionsMassimo Maffezzini
European Urology|November 6, 2007
High-risk prostate cancer is worth further risk stratificationMassimo Maffezzini
European Urology|April 11, 2008
Editorial comment on: long-term rates of undetectable psa with initial observation and delayed salvage radiotherapy after radical prostatectomyMassimo Maffezzini
European Urology|January 30, 2013
Words of Wisdom: re: trends in hospital volume and operative mortality for high-risk surgeryMassimo Maffezzini
European Urology|July 10, 2007
The survival of patients with bone metastases from renal cell carcinomaMassimo Maffezzini
European Urology|September 16, 2006
TC incidence increasing: spread the wordMassimo Maffezzini
The Journal of Urology|August 12, 2005
Re: Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term resultsMassimo Maffezzini
European Urology|May 19, 2006
Re: Richard J. Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck, J. Alfred Witjes, Christian Bouffioux, Louis Denis and Donald W.W. Newling. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466-77Massimo Maffezzini
European Urology|October 23, 2010
Words of Wisdom. Re: urinary diversion and morbidity after radical cystectomy for bladder cancerMassimo Maffezzini
European Urology|November 25, 2010
For wider acceptance of radical cystectomy and extended pelvic lymphadenectomyMassimo Maffezzini
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Surgical Oncology|April 4, 2009
The magnitude of the problem and the burden of physicians and patient decisionsMassimo Maffezzini
European Urology|November 6, 2007
High-risk prostate cancer is worth further risk stratificationMassimo Maffezzini
European Urology|April 11, 2008
Editorial comment on: long-term rates of undetectable psa with initial observation and delayed salvage radiotherapy after radical prostatectomyMassimo Maffezzini
European Urology|January 30, 2013
Words of Wisdom: re: trends in hospital volume and operative mortality for high-risk surgeryMassimo Maffezzini
European Urology|July 10, 2007
The survival of patients with bone metastases from renal cell carcinomaMassimo Maffezzini
European Urology|September 16, 2006
TC incidence increasing: spread the wordMassimo Maffezzini
The Journal of Urology|August 12, 2005
Re: Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term resultsMassimo Maffezzini
European Urology|May 19, 2006
Re: Richard J. Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck, J. Alfred Witjes, Christian Bouffioux, Louis Denis and Donald W.W. Newling. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466-77Massimo Maffezzini
European Urology|October 23, 2010
Words of Wisdom. Re: urinary diversion and morbidity after radical cystectomy for bladder cancerMassimo Maffezzini
European Urology|November 25, 2010
For wider acceptance of radical cystectomy and extended pelvic lymphadenectomyMassimo Maffezzini
Pageof 8